SNCA and Parkinson disease: Undoubtedly, all the attempts aimed to reduce α-synuclein-induced alterations (including prevention of its aggregation and dissemination or enhancing degradation of α-synuclein aggregates) would be efficient in restoring the neurogenesis in PD-affected brains, thereby contributing to functional recovery [29].